Literature DB >> 23261874

Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior.

Gregory V Carr1, Kimberly A Jenkins, Daniel R Weinberger, Francesco Papaleo.   

Abstract

The dystrobrevin-binding protein 1 (DTNBP1) gene, which encodes the dysbindin-1 protein, is a potential schizophrenia susceptibility gene. Polymorphisms in the DTNBP1 gene have been associated with altered cognitive abilities. In the present study, dysbindin-1 null mutant (dys-/-), heterozygous (dys+/-), and wild-type (dys+/+) mice, on a C57BL/6J genetic background, were tested in either a match to sample or nonmatch to sample visual discrimination task. This visual discrimination task was designed to measure rule learning and detect any changes in response timing over the course of testing. Dys-/- mice displayed significant learning deficits and required more trials to acquire this task. However, once criterion was reached, there were no differences between the genotypes on any behavioral measures. Dys-/- mice exhibited increased compulsive and impulsive behaviors compared to control littermates suggesting the inability to suppress incorrectly-timed responses underlies their increased time to acquisition. Indeed, group comparisons of behavior differences between the first and last day of testing showed that only dys-/- mice consistently decreased measures of perseverative, premature, timeout, and total responses. These findings illustrate how some aspects of altered cognitive performance in dys-/- mice might be related to increased impulsive and compulsive behaviors, analogous to cognitive deficits in some individuals with psychiatric disorders. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261874      PMCID: PMC3556458          DOI: 10.1016/j.bbr.2012.12.021

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  51 in total

1.  Strain-dependent differences in LTP and hippocampus-dependent memory in inbred mice.

Authors:  P V Nguyen; T Abel; E R Kandel; R Bourtchouladze
Journal:  Learn Mem       Date:  2000 May-Jun       Impact factor: 2.460

2.  Top-down control of motor cortex ensembles by dorsomedial prefrontal cortex.

Authors:  Nandakumar S Narayanan; Mark Laubach
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

3.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

4.  Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning.

Authors:  Gemma L Dalton; Liya M Ma; Anthony G Phillips; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2011-03-08       Impact factor: 4.530

5.  Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.

Authors:  M A Benson; S E Newey; E Martin-Rendon; R Hawkes; D J Blake
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

6.  Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.

Authors:  Yukihiko Iizuka; Yoshitatsu Sei; Daniel R Weinberger; Richard E Straub
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

9.  Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.

Authors:  James David Jentsch; Heather Trantham-Davidson; Corey Jairl; Matthew Tinsley; Tyrone D Cannon; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2009-07-29       Impact factor: 7.853

10.  Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice.

Authors:  Jonathan L Brigman; Jessica Ihne; Lisa M Saksida; Timothy J Bussey; Andrew Holmes
Journal:  Front Behav Neurosci       Date:  2009-02-23       Impact factor: 3.558

View more
  12 in total

1.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

2.  Disrupted-in-schizophrenia 1 (DISC1) regulates dysbindin function by enhancing its stability.

Authors:  Seol-Ae Lee; Seong-Mo Kim; Bo Kyoung Suh; Hwa-Young Sun; Young-Un Park; Ji-Ho Hong; Cana Park; Minh Dang Nguyen; Koh-Ichi Nagata; Joo-Yeon Yoo; Sang Ki Park
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

Review 3.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

Review 4.  Histone deacetylase-3: Friend and foe of the brain.

Authors:  Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

Review 5.  An Overview of Animal Models Related to Schizophrenia.

Authors:  Ian R Winship; Serdar M Dursun; Glen B Baker; Priscila A Balista; Ludmyla Kandratavicius; Joao Paulo Maia-de-Oliveira; Jaime Hallak; John G Howland
Journal:  Can J Psychiatry       Date:  2018-05-09       Impact factor: 4.356

6.  Behavioral characterization of mice overexpressing human dysbindin-1.

Authors:  Norihito Shintani; Yusuke Onaka; Ryota Hashimoto; Hironori Takamura; Tsuyoshi Nagata; Satomi Umeda-Yano; Akihiro Mouri; Takayoshi Mamiya; Ryota Haba; Shinsuke Matsuzaki; Taiichi Katayama; Hidenaga Yamamori; Takanobu Nakazawa; Kazuki Nagayasu; Yukio Ago; Yuki Yagasaki; Toshitaka Nabeshima; Masatoshi Takeda; Hitoshi Hashimoto
Journal:  Mol Brain       Date:  2014-10-09       Impact factor: 4.041

Review 7.  Dysbindin-1 Involvement in the Etiology of Schizophrenia.

Authors:  Haitao Wang; Jiangping Xu; Philip Lazarovici; Wenhua Zheng
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

8.  Sleep/Wake Disruption in a Mouse Model of BLOC-1 Deficiency.

Authors:  Frank Y Lee; Huei-Bin Wang; Olivia N Hitchcock; Dawn Hsiao Loh; Daniel S Whittaker; Yoon-Sik Kim; Achilles Aiken; Collette Kokikian; Esteban C Dell'Angelica; Christopher S Colwell; Cristina A Ghiani
Journal:  Front Neurosci       Date:  2018-11-15       Impact factor: 4.677

9.  Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala.

Authors:  Cathy C Y Huang; Kevin J Muszynski; Vadim Y Bolshakov; Darrick T Balu
Journal:  Transl Psychiatry       Date:  2019-04-09       Impact factor: 6.222

10.  Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7.

Authors:  Giovanni Luca Romano; Chiara Bianca Maria Platania; Gian Marco Leggio; Sebastiano Alfio Torrisi; Salvatore Giunta; Salvatore Salomone; Michele Purrello; Marco Ragusa; Cristina Barbagallo; Frank J Giblin; Rosa Mastrogiacomo; Francesca Managò; Maurizio Cammalleri; Francesco Papaleo; Filippo Drago; Claudio Bucolo
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.